Sm. Eulau et al., EFFECT OF COMBINED TRANSIENT ANDROGEN DEPRIVATION AND IRRADIATION FOLLOWING RADICAL PROSTATECTOMY FOR PROSTATIC-CANCER, International journal of radiation oncology, biology, physics, 41(4), 1998, pp. 735-740
Citations number
34
Categorie Soggetti
Oncology,"Radiology,Nuclear Medicine & Medical Imaging
Purpose: To evaluate whether transient androgen deprivation improves o
utcome in patients irradiated after radical prostatectomy for locally
advanced disease, persistent or rising postoperative prostate specific
antigen (PSA), or local recurrence, Methods and Materials: Records of
105 consecutive patients who were treated with pelvic irradiation aft
er radical retropubic prostatectomy between August 1985 and December 1
995 were reviewed. Seventy-four patients received radiation alone (mea
n follow up: 4.6 years), and 31 received transient androgen blockade w
ith a gonadotropin-releasing hormone agonist (4) androgen receptor blo
cker (1) or both (24) beginning 2 months prior to irradiation (mean fo
llow-up 3.0 years) for a mean duration of 6 months. Two of these patie
nts were excluded from further analysis because they received hormonal
therapy for more than 1 year. Patients received a prostatic fossa dos
e of 60-70 Gy at 2 Gy per fraction; 48 patients also received pelvic n
odal irradiation to a median dose of 50 Gy. Survival, freedom from cli
nical relapse (FFCR), and freedom from biochemical relapse (FFBR) were
evaluated by the Kaplan-Meier method. Biochemical relapse was defined
as two consecutive PSA measurements exceeding 0.07 ng/ml. Results: At
5 years after irradiation, actuarial survival for all patients was 92
%, FFCR was 77%, and FFBR was 34%. FFBR was significantly better among
patients who received transient androgen blockade before and during r
adiotherapy than among those treated with radiation alone (56 vs. 27%
at 5 years, p = 0.004). FFCR was also superior for the combined treatm
ent group (100 vs. 70% at 5 Sears, p = 0.014). Potential clinical prog
nostic factors before irradiation did not differ significantly between
treatment groups, including tumor stage, summed Gleason histologic sc
ore, lymph node status, indication for treatment, and PSA levels befor
e surgery or subsequent treatment, Multivariate analysis revealed that
transient androgen deprivation was the only significant predictor for
biochemical failure. Conclusion: This retrospective study of irradiat
ion after radical prostatectomy suggests that transient androgen block
ade and irradiation may improve freedom from early biochemical and cli
nically evident relapse compared to radiotherapy atone, although more
prolonged follow-up will be needed to assess durability of impact upon
clinical recurrence and survival rates. (C) 1998 Elsevier Science Inc
.